Pediatric Autoimmune Neuropsychiatric Disorder Insurance Coverage Mandate
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-06-10 — Insurance: health insurers; coverage for epinephrine; require. Amends 1956 PA 218 (MCL 500.100 - 500.8302) by adding sec. 3406ww.: cross-connection with epinephrine-coverage-mandate: Both are targeted disease/condition-specific insurance coverage mandates added to 1956 PA 218. (novelty: 2)
- 2026-06-30 — Insurance: insurers; coverage for certain pediatric autoimmune neuropsychiatric disorders; require. Amends 1956 PA 218 (MCL 500.100 - 500.8302) by adding sec. 3406pp.: 2026-07-01 — HB 6148 (103rd Legislature) would amend 1956 PA 218 by adding sec. 3406pp to require insurers to cover certain pediatric autoimmune neuropsychiatric disorders (PANS/PANDAS); the bill has been introduced and electronically reproduced. (novelty: 3) (novelty: 3)
Open questions
Related
Contributing findings
Insurance: insurers; coverage for certain pediatric autoimmune neuropsychiatric disorders; require. Amends 1956 PA 218 (MCL 500.100 - 500.8302) by adding sec. 3406pp.
30-jun-2026
novelty 3
per-area 3
introduces